Natera NTRA
NASDAQ NTRA
$366.36 +21.02 (+6.08%)
As of: Sep 17, 2026 · 3:59 PM EDT

Natera (NTRA) Cash from Financing Activities (2014 - 2026)

Natera's (NTRA) quarterly Cash from Financing Activities came in at $12.2 million in Q2 2026, down 2.94% on a YoY basis from $12.6 million in Q2 2025, and up 224.8% quarter-over-quarter from $3.8 million in Q1 2026.

Analysis

Natera (NTRA) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Natera (NTRA) has reported Cash from Financing Activities for 13 consecutive years, with $12.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities fell 2.94% year-over-year to $12.2 million; the trailing twelve-month figure through Jun 2026 stood at $50.3 million (up 94.87% YoY), and the FY2025 full-year result was $47.5 million, up 57.13% from the prior year.
  • Cash from Financing Activities rose to $12.2 million in Q2 2026 per NTRA's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $468.2 million in Q4 2022 and bottomed at $544000.0 in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $46.2 million across 5 years, with a median of $7.9 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 99.75% in 2022, then soared 16842.07% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $468.2 million in 2022, then sank by 98.54% to $6.8 million in 2023, then jumped by 60.32% to $11.0 million in 2024, then jumped by 195.3% to $32.4 million in 2025, then plunged by 62.33% to $12.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $12.2 million, $3.8 million, and $32.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 12.21 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -229.00 Mn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -919.90 Mn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 23.01 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 97.12 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -36.90 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -2.41 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn 6.09 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 142.19 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 4.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.21 Mn
Mar 31, 2026 3.76 Mn
Dec 31, 2025 32.41 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 12.58 Mn
Mar 31, 2025 544,000.00
Dec 31, 2024 10.97 Mn
Sep 30, 2024 1.72 Mn
Jun 30, 2024 11.04 Mn
Mar 31, 2024 6.47 Mn
Dec 31, 2023 6.85 Mn
Sep 30, 2023 236.00 Mn
Jun 30, 2023 9.31 Mn
Mar 31, 2023 2.30 Mn
Dec 31, 2022 468.17 Mn
Sep 30, 2022 1.39 Mn
Jun 30, 2022 8.92 Mn
Mar 31, 2022 4.16 Mn
Dec 31, 2021 8.52 Mn
Sep 30, 2021 554.76 Mn